Amylyxs

0

Amylyx’s ALS drug gets U.S. FDA panel’s backing in rare turnaround

September 8, 2022

Test tubes are seen in front of Amylyx logo in this illustration, July 24, 2022. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.comRegister Sept 7 (Reuters) – Amylyx Pharmaceuticals Inc’s (AMLX.O . . .

0

U.S. FDA panel votes against Amylyx’s ALS drug over trial data concerns

March 30, 2022

March 30 (Reuters) – A panel of outside advisers to the U.S. Food and Drug Administration on Wednesday voted against approving Amylyx Pharmaceuticals Inc’s (AMLX.O) drug for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. The FDA advisory committee voted 6 to 4 against the treatment, saying . . .

Current track

Title

Artist